New Zealand dairy giant Fonterra is diversifying its business with the launch of BioKodeLab – a supplement brand aimed at improving cognitive performance.
“I think it’s really important for the field to understand what the baseline understanding and criteria are for these substances so that the whole scientific and commercial and regulatory world can coalesce around definitions that make the most sense,”...
A New Zealand probiotic company is aiming to broaden the health claims applicable for its flagship probiotic strain BLIS K12 in the area of upper respiratory health, following favourable findings published recently.
A new survey of Turkish footballers has revealed insights into why and how these athletes consume supplements as well as some of the sex discrepancies in consumption.
The HMO opportunity, synbiotic mechanisms of action, phages, personalisation, and the gut-brain axis are just some of the topics to be explored at the 2023 event in Barcelona, Spain.
Daily consumption of three probiotic strains may led to changes in connectivity between various regions of the brain and exert subtle improvements on psychological health, says a new study using a GSK product.
A clinical trial has concluded that a daily cocktail of six probiotic strains can improve metabolic outcomes, gut microbial profiles, and certain inflammatory markers in women with post-gestational diabetes.
Two lactic acid bacteria (LAB) strains found in fermented Malaysian tapioca have shown antimicrobial properties for the prevention of periodontal disease, characterised by inflamed and progressively receding gingival tissue.
Supplementation with Lacticaseibacillus casei 63 (L. casei 63) may help reduce sarcopenia in frail elderly people by promoting insulin sensitivity, metabolic efficiency, and muscle protein anabolism, according to a French study.
The potential health benefits of Akkermansia muciniphila may include changing the expression of genes associated with immune pathways, according to a new paper.
Dietary supplementation with a specific Lactiplantibacillus plantarum strain may significantly reduce body weight, BMI, and waist circumferences in the overweight/obese subjects, says a new study.
Administration of the probiotic Lactobacillus paragasseri (L. paragasseri) OLL2809 stimulates an abundance of healthy gut bacteria that may help alleviate depressive symptoms.
Next generation Bifidobacteria probiotics developed using CRISPR gene editing technology are one step closer after a new paper showed how select techniques could be applied in a programmable and strain-dependent manner.
The global gut health is variously estimated at around €15-30 billion and predicted to grow by around 8% annually at least to the end of the decade, but what are the opportunities and hurdles for companies wanting to win in it?
Supplementation with Lacticaseibacillus rhamnosus GG (LGG) stimulates butyrate production and can minimise the severity of atopic dermatitis (AD) in children, say researchers.
Probiotic supplements may improve general health and reduce the incidence of selected gastrointestinal (GI) disturbances in long-distance runners, researchers say.
Administration of the probiotic L. coryniformis helps sustain immune responses and mitigates the effectiveness of the COVID-19 vaccination, according to a team of Spanish scientists.
Supplementing the diet of six-month old babies born via caesarean section with Lacticaseibacillus paracasei N1115 may improve gastrointestinal function, with no safety concerns, says a new study.
Prolonged addition of a probiotic supplement or food into the diet of seniors may support healthy ageing by shifting their gut microbiota and reducing markers of inflammation, according to results of the Italian ProbioSenior Project.
This round-up will feature scientific findings from big brand names, including Swisse and its study of krill oil supplementation on knee osteoarthritis, Amway’s personalised nutrition, and India’s national research agency’s plans for studying cannabidiol...
The roles of the microbiome and probiotics in supporting the menopause could be a key growth area as the process, combined with healthy ageing and gut health, gives rise to niche products aimed at women navigating this stage of life.
A combination of bacteriophages (phages) may precisely target and suppress gut bacteria associated with inflammatory bowel diseases (IBD), says a new study from Israel that shows the potential of this emerging class of microbiome modulators.
Commercial predictive modelling for personalised nutrition requires proper validation to maximise inclusivity and achieve optimal health benefits, say experts.
Nestlé Health Science and Enterome are to co-develop and commercialise a series of microbiome-based immunotherapies for food allergies and inflammatory bowel disease (IBD).
Consumption of probiotics could ease constipation, improve stool consistency and increase faecal Bifidobacteria and Lactobacillus among people with irritable bowel syndrome (IBS-C)
Thorne HealthTech recently relaunched its Gut Health Test with the inclusion of its patent-pending Microbiome Wipe, eliminating the stool sampling that might be deterring users from testing their microbiome.
The joint development program between Seed and Axial aims to develop next-generation probiotics and therapeutics to modulate the gut microbiota to target areas like anxiety, depression and mental well-being.
Specific probiotics strains have showed immunomodulatory properties in women suffering from chronic inflammatory conditions, such as gestational diabetes and PCOS, according to a review of RCTs conducted by Nestle.
This round-up will look at developments of brands in the health and nutrition industry, including how brands such as Bubs Australia and Bellamy’s Organic have successfully gained access to the infant formula market in US, as well as Nestle Health Science’s...
Greek biopharmaceutical firm Cloudpharm is to team up with Cosmos Holdings in a deal that harnesses the gut microbiome as a basis to develop products addressing obesity.
The Akkermansia Company, formerly called A-Mansia Biotech, has revealed its new brand name along with plans to launch food supplement Akkermansia muciniphila.
Researchers from the UK’s Quadram Institute present new evidence that points to the maternal microbiome influence on the baby’s mental and physical development.
Oral consumption of heat-killed Lactiplantibacillus plantarum L-137 may improve moisture in the skin and help people with dry skin, says a new study from Japan.
Scientists have detailed a new approach for studying microbiota functionality that uses mass spectrometry to define protein levels in microbiota samples and identify specific cell function.
Obese children may benefit from a synbiotic combination of probiotics and a prebiotic, with 12 weeks of supplementation linked to significant decreases in body weight, BMI, and waist size.
Consuming a kimchi-derived probiotic bacterium may reduce levels of harmful advanced glycation end products (AGE), compounds produced when food is cooked at high temperatures for a long time.
With consumers increasingly demanding scientifically-validated nutra products and ingredients, one of the key scientists in Australia’s national research agency has revealed the three factors that are crucial for a high-quality trial.
The authors of a recent review assert that all diet-related chronic diseases are linked to the microbiome but there is limited consideration of these interactions in contemporary dietary guidelines.
Swiss researchers at the University of Basel assert that high-dose probiotics can reduce the symptoms of major depressive disorder (MDD) and suggest supplementation as a possible “non-stigmatising” add-on therapy.
Dietary supplementation with novel probiotics isolated from Korean kimchi may slash body weight and reduce abdominal fat in overweight people, says a new study from Korea.
Probiotic formulators are increasingly turning to prebiotics like dietary fibres, polyphenols, fructo-oligosaccharides and lactulose, with 51% of probiotic supplements tracked by Lumina Intelligence containing a prebiotic of some kind.
OptiBiotix continues to expand its presence in the microbiome health space after the recent listing of of its subsidiary ProBiotix Health on London’s Aquis Stock Exchange.